To compare the relation between IGF1 and treatment response, the authors compared the levels of IGF1 in patients with a Hamilton depression rating scale (HAM-D) 21-item score < 10 after 6 weeks of psychopharmacological treatment and those without remission. This evidence concerns the gene IGF1 and depressive symptom measurement.